Results 241 to 250 of about 268,157 (315)

Cryopreservation practices in clinical and preclinical iPSC‐based cell therapies: Current challenges and future directions

Biotechnology Progress, EarlyView.
Abstract Induced pluripotent stem cells (iPSCs) offer significant therapeutic potential, but cryopreservation challenges, particularly the reliance on cytotoxic Dimethyl Sulfoxide (Me2SO), hinder their clinical application. This review examines current cryopreservation practices in clinical and preclinical iPSC‐based therapies, highlighting the ...
Michael Dobruskin, Geoffrey Toner, Ronald Kander   +2 more
wiley   +1 more source

Potential role of endothelial progenitor cells in the pathogenesis and treatment of cerebral aneurysm. [PDF]

Front Cell Neurosci
Yu J, Du Q, Li X, Wei W, Fan Y, Zhang J, Chen J.   +6 more
europepmc   +1 more source

Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis. [PDF]

Immunity, 2023
Do MH, Shi W, Ji L, Ladewig E, Zhang X, Srivastava RM, Capistrano KJ, Edwards C, Malik I, Nixon BG, Stamatiades EG, Liu M, Li S, Li P, Chou C, Xu K, Hsu TW, Wang X, Chan TA, Leslie CS, Li MO.   +20 more
europepmc   +1 more source

p21 ^Cip1 Levels Differentially Regulate Turnover of Mature Endothelial Cells, Endothelial Progenitor Cells, and In Vivo Neovascularization [PDF]

, 2004
Tom Brühl, Christopher Heeschen, Alexandra Aicher, Amir S. Jadidi, Judith Haendeler, Jörg Hoffmann, Michael Schneider, Andreas M. Zeiher, Stefanie Dimmeler, Lothar Rössig   +9 more
openalex   +1 more source

Blocking ITGA5 potentiates the efficacy of anti‐PD‐1 therapy on glioblastoma by remodeling tumor‐associated macrophages

Cancer Communications, EarlyView.
Abstract Background Glioblastoma (GBM) is largely refractory to antibodies against programmed cell death 1 (anti‐PD‐1) therapy. Fully understanding the cellular heterogeneity and immune adaptations in response to anti‐PD‐1 therapy is necessary to design more effective immunotherapies for GBM.
Rongrong Zhao, Ziwen Pan, Jiawei Qiu, Boyan Li, Yanhua Qi, Zijie Gao, Wei Qiu, Weijie Tang, Xiaofan Guo, Lin Deng, Gang Li, Hao Xue   +11 more
wiley   +1 more source

The study of miR-130a expression and its mechanism of action in peripheral blood endothelial progenitor cells (EPCs) in type 2 diabetes mellitus (T2DM). [PDF]

Sci Rep
Cai Y, Zhu Y, Xu N, Chen T.
europepmc   +1 more source

Endothelial Progenitor Cells at Work [PDF]

, 2004
Lothar Rössig, Carmen Urbich, Stefanie Dimmeler   +2 more
openalex   +1 more source

Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation

Cancer Communications, EarlyView.
Abstract Background Hepatocellular carcinoma (HCC) is a deadly malignancy known for its ability to evade immune surveillance. NOP2/Sun RNA methyltransferase family member 2 (NSUN2), an RNA methyltransferase involved in carcinogenesis, has been associated with immune evasion and energy metabolism reprogramming.
Jinhua Jiang, Feng Liu, Dan Cui, Caixia Xu, Jiachang Chi, Tinghua Yan, Fang Guo   +6 more
wiley   +1 more source

The effect of empagliflozin on circulating endothelial progenitor cells in patients with diabetes and stable coronary artery disease. [PDF]

Cardiovasc Diabetol
Hershenson R, Nardi-Agmon I, Leshem-Lev D, Kornowski R, Eisen A.   +4 more
europepmc   +1 more source

831-3 Circulating endothelial progenitor cells predict coronary artery disease severity

, 2004
Geoffrey A. Kunz, Grace Liang, Florim Cuculoski, David Gregg, Korkut C. Vata, Linda Shaw, Pascal J. Goldschmidt‐Clermont, Chunming Dong, Doris Taylor, Eric D. Peterson   +9 more
openalex   +1 more source